- Home
- MEOH vs XENE Comparison
MEOH vs XENE Comparison
Compare MEOH & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEOH
- XENE
- Stock Information
- Founded
- MEOH 1968
- XENE 1996
- Country
- MEOH Canada
- XENE Canada
- Employees
- MEOH N/A
- XENE N/A
- Industry
- MEOH Major Chemicals
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- MEOH Industrials
- XENE Health Care
- Exchange
- MEOH Nasdaq
- XENE Nasdaq
- Market Cap
- MEOH 2.2B
- XENE 2.4B
- IPO Year
- MEOH N/A
- XENE 2014
- Fundamental
- Price
- MEOH $34.02
- XENE $32.09
- Analyst Decision
- MEOH Buy
- XENE Strong Buy
- Analyst Count
- MEOH 9
- XENE 11
- Target Price
- MEOH $46.89
- XENE $54.82
- AVG Volume (30 Days)
- MEOH 731.0K
- XENE 1.4M
- Earning Date
- MEOH 07-29-2025
- XENE 08-07-2025
- Dividend Yield
- MEOH 2.18%
- XENE N/A
- EPS Growth
- MEOH 24.27
- XENE N/A
- EPS
- MEOH 3.06
- XENE N/A
- Revenue
- MEOH $3,700,592,000.00
- XENE $7,500,000.00
- Revenue This Year
- MEOH $10.01
- XENE N/A
- Revenue Next Year
- MEOH $14.10
- XENE $253.71
- P/E Ratio
- MEOH $11.08
- XENE N/A
- Revenue Growth
- MEOH 2.77
- XENE N/A
- 52 Week Low
- MEOH $25.46
- XENE $26.74
- 52 Week High
- MEOH $54.49
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- MEOH 43.29
- XENE 51.38
- Support Level
- MEOH $33.37
- XENE $31.34
- Resistance Level
- MEOH $35.47
- XENE $32.99
- Average True Range (ATR)
- MEOH 1.38
- XENE 1.23
- MACD
- MEOH -0.33
- XENE 0.09
- Stochastic Oscillator
- MEOH 0.10
- XENE 42.19
About MEOH Methanex Corporation
Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.